Intestinal immune defences and the inflammatory response in necrotising enterocolitis

Seminars in Fetal and Neonatal Medicine

Volumn 11, Issue 5, 2006, Pages 369-377

  Martin, Camilia R ^a   Walker, W Allan ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemokines; Cytokines; Enterocolitis, necrotising; Growth factors; Infant, premature; Inflammation; Matrix metalloproteinases; Nuclear factor kappa B; Toll like receptors

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANTIBIOTIC AGENT; ARGININE; CHEMOKINE; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 11; MATRIX METALLOPROTEINASE; OMEGA 3 FATTY ACID; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL COLONIZATION; CLINICAL FEATURE; CLINICAL TRIAL; EMERGENCY; ENTERIC FEEDING; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNITY; INTESTINE INJURY; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; PATHOPHYSIOLOGY; RISK FACTOR;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTESTINES; PREVALENCE; RISK FACTORS;

EID: 33745835469     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2006.03.002     Document Type: Article

References (78)

1. Hintz S.R., Kendrick D.E., Stoll B.J., et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 115 (2005) 696-703
2. Simon N.P. Follow-up for infants with necrotizing enterocolitis. Clin Perinatol 21 (1994) 411-424
3. Stoll B.J. Epidemiology of necrotizing enterocolitis. Clin Perinatol 21 (1994) 205-218
4. Lemons J.A., Bauer C.R., Oh W., et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107 (2001) E1
5. Caplan M., and Jilling T. The pathophysiology of necrotizing enterocolitis. NeoReviews 2 (2001) c103-c108
6. Walker W.A. Development of the intestinal mucosal barrier. J Pediatr Gastroenterol Nutr 34 Suppl. 1 (2002) S33-S39
7. Forchielli M.L., and Walker W.A. The effect of protective nutrients on mucosal defense in the immature intestine. Acta Paediatr Suppl 94 (2005) 74-83
8. Claud E.C., and Walker W.A. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 15 (2001) 1398-1403
9. Fusunyan R.D., Nanthakumar N.N., Baldeon M.E., and Walker W.A. Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res 49 (2001) 589-593
10. Claud E.C., Lu L., Anton P.M., Savidge T., Walker W.A., and Cherayil B.J. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA 101 (2004) 7404-7408
11. Nanthakumar NN, Walker WA. Personal communication, 2005.
12. Caplan M.S., and MacKendrick W. Inflammatory mediators and intestinal injury. Clin Perinatol 21 (1994) 235-246
13. Hsueh W., and Gonzalez-Crussi F. Ischemic bowel necrosis induced by platelet-activating factor: an experimental model. Methods Achiev Exp Pathol 13 (1988) 208-239
14. Ewer A.K., Al-Salti W., Coney A.M., Marshall J.M., Ramani P., and Booth I.W. The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. Gut 53 (2004) 207-213
15. Hsueh W., Gonzalez-Crussi F., and Arroyave J.L. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1 (1987) 403-405
16. Caplan M.S., Sun X.M., and Hsueh W. Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether). Gastroenterology 99 (1990) 979-986
17. Llausas-Magana E., Hsueh W., Arroyave C.M., Arroyave J.L., Torre-Amione G., and Gonzalez-Crussi F. Cobra venom factor, an activator of the complement system, enhances the bowel necrosis induced by platelet-activating factor. Immunopharmacology 15 (1988) 31-37
18. Hsueh W., Caplan M.S., Sun X., Tan X., MacKendrick W., and Gonzalez-Crussi F. Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. Acta Paediatr Suppl 396 (1994) 11-17
19. Rabinowitz S.S., Dzakpasu P., Piecuch S., Leblanc P., Valencia G., and Kornecki E. Platelet-activating factor in infants at risk for necrotizing enterocolitis. J Pediatr 138 (2001) 81-86
20. Caplan M.S., Sun X.M., Hseuh W., and Hageman J.R. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 116 (1990) 960-964
21. Amer M.D., Hedlund E., Rochester J., and Caplan M.S. Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate 85 (2004) 159-166
22. MacKendrick W., Hill N., Hsueh W., and Caplan M. Increase in plasma platelet-activating factor levels in enterally fed preterm infants. Biol Neonate 64 (1993) 89-95
23. Birk D., Berger D., Limmer J., and Beger H.G. Is the elimination of endotoxin and cytokines with continuous lavage an alternative procedure in necrotizing enterocolitis?. Acta Paediatr Suppl 396 (1994) 24-26
24. Viscardi R.M., Lyon N.H., Sun C.C., Hebel J.R., and Hasday J.D. Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine. Pediatr Pathol Lab Med 17 (1997) 547-559
25. Pender S.L., Braegger C., Gunther U., et al. Matrix metalloproteinases in necrotising enterocolitis. Pediatr Res 54 (2003) 160-164
26. Tan X., Hsueh W., and Gonzalez-Crussi F. Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages. Am J Pathol 142 (1993) 1858-1865
27. Morecroft J.A., Spitz L., Hamilton P.A., and Holmes S.J. Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatr Suppl 396 (1994) 18-20
28. Harris M.C., Costarino Jr. A.T., and Sullivan J.S. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. [see comments]. J Pediatr 124 (1994) 105-111
29. Ren Y., Lin C.L., Li Z., et al. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology 46 (2005) 659-667
30. Duffy L.C., Zielezny M.A., Carrion V., et al. Concordance of bacterial cultures with endotoxin and interleukin-6 in necrotizing enterocolitis. Dig Dis Sci 42 (1997) 359-365
31. Halpern M.D., Holubec H., Dominguez J.A., et al. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 51 (2002) 733-739
32. Nadler E.P., Stanford A., and Zhang X.R. Intestinal cytokine gene expression in infants with acute necrotizing enterocolitis: interleukin-11 mRNA expression inversely correlates with extent of disease. J Pediatr Surg 36 (2001) 1122-1129
33. Edelson M.B., Bagwell C.E., and Rozycki H.J. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103 (1999) 766-771
34. Nanthakumar N.N., Fusunyan R.D., Sanderson I., and Walker W.A. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 97 (2000) 6043-6048
35. Ballance W.A., Dahms B.B., Shenker N., and Kliegman R.M. Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr 117 (1990) S6-S13
36. Bister V., Salmela M.T., Heikkila P., et al. Matrilysins-1 and -2 (MMP-7 and -26) and metalloelastase (MMP-12), unlike MMP-19, are up-regulated in necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 40 (2005) 60-66
37. Pender S.L., Tickle S.P., Docherty A.J., Howie D., Wathen N.C., and MacDonald T.T. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 158 (1997) 1582-1590
38. Caplan M.S., Lickerman M., Adler L., Dietsch G.N., and Yu A. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 42 (1997) 779-783
39. Muguruma K., Gray P.W., Tjoelker L.W., and Johnston J.M. The central role of PAF in necrotizing enterocolitis development. Adv Exp Med Biol 407 (1997) 379-382
40. Furukawa M., Lee E.L., and Johnston J.M. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. Pediatr Res 34 (1993) 237-241
41. Furukawa M., Narahara H., Yasuda K., and Johnston J.M. Presence of platelet-activating factor-acetylhydrolase in milk. J Lipid Res 34 (1993) 1603-1609
42. Caplan M., Hsueh W., Kelly A., and Donovan M. Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 39 (1990) 705-714
43. Chheda S., Palkowetz K.H., Garofalo R., Rassin D.K., and Goldman A.S. Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor-alpha and its receptors. Pediatr Res 40 (1996) 475-483
44. Kotiranta-Ainamo A., Rautonen J., and Rautonen N. Interleukin-10 production by cord blood mononuclear cells. Pediatr Res 41 (1997) 110-113
45. Le T., Leung L., Carroll W.L., and Schibler K.R. Regulation of interleukin-10 gene expression: possible mechanisms accounting for its upregulation and for maturational differences in its expression by blood mononuclear cells. Blood 89 (1997) 4112-4119
46. Jones C.A., Cayabyab R.G., Kwong K.Y., et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 39 (1996) 966-975
47. Steidler L., Hans W., Schotte L., et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289 (2000) 1352-1355
48. Ozturk H., Dokucu A.I., Ogun C., and Buyukbayram H. Protective effects of recombinant human interleukin-10 on intestines of hypoxia-induced necrotizing enterocolitis in immature rats. J Pediatr Surg 37 (2002) 1330-1333
49. Du X., Liu Q., Yang Z., et al. Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am J Physiol 272 (1997) G545-G552
50. Dvorak B., Halpern M.D., Holubec H., et al. Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model. Pediatr Res 53 (2003) 426-433
51. Fituch C.C., Palkowetz K.H., Goldman A.S., and Schanler R.J. Concentrations of IL-10 in preterm human milk and in milk from mothers of infants with necrotizing enterocolitis. Acta Paediatr 93 (2004) 1496-1500
52. Claud E.C., Savidge T., and Walker W.A. Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res 53 (2003) 419-425
53. Ford H., Watkins S., Reblock K., and Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 32 (1997) 275-282
54. Miettinen P.J. Epidermal growth factor receptor in mice and men - any applications to clinical practice?. Ann Med 29 (1997) 531-534
55. Dvorak B., Halpern M.D., Holubec H., et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 282 (2002) G156-G164
56. Halpern M.D., Dominguez J.A., Dvorakova K., et al. Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. J Pediatr Gastroenterol Nutr 36 (2003) 126-133
57. Fagbemi A.O., Wright N., Lakhoo K., and Edwards A.D. Immunoreactive epidermal growth factor receptors are present in gastrointestinal epithelial cells of preterm infants with necrotising enterocolitis. Early Hum Dev 65 (2001) 1-9
58. Shin C.E., Falcone Jr. R.A., Stuart L., Erwin C.R., and Warner B.W. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 35 (2000) 173-176 discussion 7
59. Treszl A., Kocsis I., Szathmari M., Schuler A., Tulassay T., and Vasarhelyi B. Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr 90 (2001) 1182-1185
60. Treszl A., Heninger E., Kalman A., Schuler A., Tulassay T., and Vasarhelyi B. Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 38 (2003) 1374-1378
61. O'Neill L.A. How NOD-ing off leads to Crohn disease. Nat Immunol 5 (2004) 776-778
62. Romero R., Gomez R., Ghezzi F., et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 179 (1998) 186-193
63. Yoon B.H., Romero R., Kim K.S., et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 181 (1999) 773-779
64. Yoon B.H., Romero R., Park J.S., et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 182 (2000) 675-681
65. Yoon B.H., Romero R., Yang S.H., et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174 (1996) 1433-1440
66. Leviton A., Paneth N., Reuss M.L., et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 46 (1999) 566-575
67. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., and Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 179 (1998) 194-202
68. Dammann O., and Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 12 (2000) 99-104
69. Martinez-Tallo E., Claure N., and Bancalari E. Necrotizing enterocolitis in full-term or near-term infants: risk factors. Biol Neonate 71 (1997) 292-298
70. Uauy R.D., Fanaroff A.A., Korones S.B., Phillips E.A., Phillips J.B., and Wright L.L. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 119 (1991) 630-638
71. Mercer B.M., Miodovnik M., Thurnau G.R., et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. J Am Med Assoc 278 (1997) 989-995
72. Kenyon S., Boulvain M., and Neilson J. Antibiotics for preterm rupture of the membranes: a systematic review. Obstet Gynecol 104 (2004) 1051-1057
73. Kim Y.D., Hyun W.Y., and Cha H.J. Funisitis and raised interleukin 6 concentrations in gastric aspirates at birth. Arch Dis Child Fetal Neonatal Ed 90 (2005) F349-F350
74. Reber K.M., and Nankervis C.A. Necrotizing enterocolitis: preventative strategies. Clin Perinatol 31 (2004) 157-167
75. Foster J., and Cole M. Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth-weight neonates. Cochrane Database Syst Rev 1 (2004) CD001816
76. Bury R.G., and Tudehope D. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev 1 (2001) CD000405
77. Becker R.M., Wu G., Galanko J.A., et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr 137 (2000) 785-793
78. Amin H.J., Zamora S.A., McMillan D.D., et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 140 (2002) 425-431